ICVAX as a HIV Therapeutic DNA Vaccine

NCT06253533 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Immunodeficiency Virus
Human Immunodeficiency Virus I Infection

Interventions

BIOLOGICAL: ICVAX
OTHER: Placebo

Sponsor

Immuno Cure Holding (HK) Limited

Collaborators

[object Object]
[object Object]